Weight-loss drugs like Ozempic and Wegovy have become household names in recent years. But here's why they may not work for ...

WeightWatchers is shaking up its leadership. WW International announced Friday that CEO Sima Sistani would leave her role ...

Novo Nordisk CEO Lars Fruergaard Jørgensen is testifying before the Senate Health, Education, Labor and Pension committee on ...

Is Novo Nordisk helping Americans save taxpayer money or ripping them off? The company’s CEO is scheduled to testify Tuesday ...

Weight-loss drugs sell in Europe for a fraction of what they cost in the United States, a pattern that is typical for ...

Is Ozempic and Wegovy maker Novo Nordisk helping Americans save taxpayer money or ripping them off? The company's CEO ...

Novo Nordisk chief executive Lars Fruergaard Jørgensen faced questioning on Capitol Hill over the health care costs of the ...

Novo Nordisk's weight loss drug Wegovy could face Medicare price negotiations next. Meanwhile, Particle Health files an ...

Sima Sistani, who took up the CEO post at WW International two-and-a-half years ago, is out, according to the company.

Semaglutide, the underlying drug marketed as Ozempic and Wegovy, works by mimicking a hormone that triggers the body to feel ...

Although not available in India in injectible form, new weight loss drugs Ozempic and Wegovy are all the rage. Lounge speaks ...

The term "Ozempic face" is not a medical term, but some use it to describe this type of appearance after weight loss. Here what's fact and fiction.